OBJECTIVES: To determine the HRQoL scores in colorectal patients treated with a curative intent as outpatients after having completed their treatment in a tertiary hospital. METHODS: We selected patients with colorectal cancer, treated with a curative intent. At the end of the treatment we applied the EORTC questionnaires: QLQ-C30, QLQ-CR29 and IN-PATSAT32. The mean and standard deviation were calculated. The scores for questionnaires were calculated with formulas and instructions according to EORTC Scoring Manual. The scores were correlated through Pearson¨R test. RESULTS: Global health status/QoL showed a mean score of 88.26 (±16.99); the other means were: role functioning 97.73 (±7.79), emotional functioning 84.09 (±13.34), diarrhoea 15.15 (±26.68), constipation 13.64 (±19.68), urinary frequency 22.73 (±29.34), abdominal pain 7.58 (±14.30), bloating 7.58 (±14.30), dry mouth 9.09 (±18.35), sore skin 15.15 (±32.08), stoma care problems 16.67(±25.20). In the satisfaction questionnaire, the scores for doctors showed: technical skills 90.15 (±15.14) and information provision 90.91 (±16.65), for nurses: technical skills 76.89 (±24.25) and information provision 68.94 (±25.22), access 58.52 (±23.90), waiting times 54.55 (±26.32), comfort/cleanness 61.36 (±31.55) and general satisfaction 72.73 (±25.48). We also documented associations between physical functioning and body surface (rP 0.52; p 0.01), role functioning and carcinoembryonic antigen (rP-0.45; p0.03), cognitive functioning and glucose serum levels (rP-0.51; p 0.01), pain and peripheral blood leucocyte count (rP 0.73; p 0.000), sexual interest (men) and albumin serum levels (rP 0.85; p 0.01), dry mouth and glucose serum levels (rP 0.55; p 0.008) and between flatulence and glucose serum levels (rP 0.47; p 0.026).  CONCLUSIONS: Emotional functioning and psychological issues are not systematically treated at our institucion. Satisfaction with doctors was better than with nurse personnel. Malnutrition impacts negatively both in role and sexual functioning in the colorectal cancer patients.